| 1 |
Clinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments |
|
|
| David Staskin |
|
| Expert Opinion on Pharmacotherapy. 2022; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects |
|
|
| Sam Tilborghs, Stefan De Wachter |
|
| Expert Review of Medical Devices. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: Results of a randomized controlled crossover study |
|
|
| Vecchioli-Scaldazza, C. and Morosetti, C. and Berouz, A. and Giannubilo, W. and Ferrara, V. |
|
| Gynecologic and Obstetric Investigation. 2013; 75(4): 230-234 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Solifenacin Succinate versus Percutaneous Tibial Nerve Stimulation in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Crossover Study |
|
|
| Carlo Vecchioli-Scaldazza, Carolina Morosetti, Azizi Berouz, Willy Giannubilo, Vincenzo Ferrara |
|
| Gynecologic and Obstetric Investigation. 2013; 75(4): 230 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Voiding dysfunction in the female patient: Is the "syndrome" paradigm valid? |
|
|
| Tunuguntla, H.S.G.R. and Tunuguntla, R. and Barone, J. and Kanagarajah, P. and Gousse, A.E. |
|
| Current Urology Reports. 2011; 12(5): 377-380 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Repeat intradetrusor injections of onabotulinum toxin A for refractory idiopathic overactive bladder patients: A single-center experience |
|
|
| Gousse, A.E. and Kanagarajah, P. and Ayyathurai, R. and Handa, P. and Dabas, N. and Gomez, C.S. |
|
| Female Pelvic Medicine and Reconstructive Surgery. 2011; 17(5): 253-257 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Voiding Dysfunction in the Female Patient: Is the “Syndrome” Paradigm Valid? |
|
|
| Hari Siva G. R. Tunuguntla,Renuka Tunuguntla,Joseph Barone,Prashanth Kanagarajah,Angelo E. Gousse |
|
| Current Urology Reports. 2011; 12(5): 377 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Repeat Intradetrusor Injections of Onabotulinum Toxin A for Refractory Idiopathic Overactive Bladder Patients |
|
|
| Angelo E. Gousse, Prashanth Kanagarajah, Rajinikanth Ayyathurai, Priyanka Handa, Nikita Dabas, Christopher S. Gomez |
|
| Female Pelvic Medicine & Reconstructive Surgery. 2011; 17(5): 253 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Overactive Bladder Syndrome |
|
|
| Oroma B. Nwanodi,Gil Levy |
|
| Postgraduate Obstetrics & Gynecology. 2010; 30(12): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Sacral neuromodulation: Therapy evolution |
|
|
| Thompson, J.H. and Sutherland, S.E. and Siegel, S.W. |
|
| Indian Journal of Urology. 2010; 26(3): 379-384 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Lower Urinary Tract Symptoms: Defining Syndromes in Urology |
|
|
| Prashanth Kanagarajah, Rajinikanth Ayyathurai, Angelo E. Gousse |
|
| Current Bladder Dysfunction Reports. 2010; 5(4): 233 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
